Literature DB >> 1149367

Commentary. Major drug-prescribing patterns in general hospitals.

J Sicé.   

Abstract

Prescriptions of major drug classes were surveyed for one year in five teaching and five nonteaching general hospitals. Their overall rates varied over a two- to three-fold range in medicine, surgery, and pediatrics, but were uniform throughout the hospitals. Parenteral fluids and antibiotics represented over one half of the pharmacotherapy used in every specialty except medicine, where tranquilizers were the most frequently prescribed drugs. Prescribing patterns lacked consistency in obstetrics and newborn services, and generally with steroids, vasopressors, and anticoagulants. Significant variations also involved the use of fluids in pediatrics, diuretics in surgery, and vasodilators in medicine. These variations were too unpredictable and large to be attributed to specific differences among patient populations. Only two discrepancies were noted between teaching and nonteaching hospitals: tranquilizers were prescribed more often in the former, and vasopressors in the latter.

Entities:  

Mesh:

Year:  1975        PMID: 1149367     DOI: 10.1002/cpt1975182133

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

1.  Drug utilisation patterns in the Third World.

Authors:  J S Bapna; C D Tripathi; U Tekur
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

Review 2.  Use and abuse of antibiotics.

Authors:  J M Hamilton-Miller
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

3.  Patterns of drug prescribing for children in hospital.

Authors:  T A Moreland; G W Rylance; L J Christopher; I H Stevenson
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

4.  Auditing hospital drug utilisation by means of defined daily doses per bed-day. A methodological study.

Authors:  U Bergman; I Christenson; B Jansson; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.